Transplantation of engineered chimeric liver with autologous hepatocytes and xenobiotic scaffold

Annals of Surgery

Volumn 257, Issue 3, 2013, Pages 542-547

  Hata, Toshiyuki ^a,b   Uemoto, Shinji ^a   Fujimoto, Yasuhiro ^a   Murakami, Takashi ^c   Tateno, Chise ^d   Yoshizato, Katsutoshi ^d   Kobayashi, Eiji ^e  

^a KYOTO UNIVERSITY   (Japan)

^b MAYO CLINIC   (United States)

^c TAKASAKI UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^d PhoenixBio USA Corporation   (Japan)

^e JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

alternative organ graft; auxiliary liver transplantation; chimeric liver; engineered organ; liver transplantation

Indexed keywords

ALBUMIN; BETA GALACTOSIDASE; CYCLOPHOSPHAMIDE; KI 67 ANTIGEN; LUCIFERASE; TACROLIMUS; UROKINASE;

ALBUMIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHIMERIC LIVER TRANSPLANTATION; DOPPLER ECHOGRAPHY; FEASIBILITY STUDY; FEMALE; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; LIVER CELL; LIVER GRAFT; LIVER RESECTION; LIVER TRANSPLANTATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL PROLIFERATION; CHIMERA; DISEASE MODELS, ANIMAL; FEMALE; HEPATECTOMY; HEPATOCYTES; LIVER; LIVER TRANSPLANTATION; MALE; MICE; MICE, SCID; RATS; RATS, INBRED LEW; TISSUE SCAFFOLDS; TRANSPLANTATION, HETEROLOGOUS; XENOBIOTICS;

EID: 84873992522     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31825c5349     Document Type: Article

References (36)

1. Thuluvath PJ, GuidingerMK, Fung JJ, et al. Liver transplantation in the United States, 1999-2008. Am J Transplant. 2010;10:1003-1019.
2. Yeh H, Smoot E, Schoenfeld DA, et al. Geographic inequity in access to livers for transplantation. Transplantation. 2011;91:479-486.
3. Ohashi K, Yokoyama T, Yamato M, et al. Engineering functional two-and three-dimensional liver systems in vivo using hepatic tissue sheets. Nat Med. 2007;13;880-885.
4. Soto-Gutíerrez A, Kobayashi N, Rivas-Carrillo JD, et al. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat Biotechnol. 2006;24:1412-1419.
5. Ott HC, Matthiesen TS, Goh SK, et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med. 2008;14:213-221.
6. Uygaun BE, Soto-Gutierrez A, Yagi H, et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med. 2010;16:814-820.
7. Kobayashi T, Yamaguchi T, Hamanaka S, et al. Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells. Cell. 2010;142:787-799.
8. Ekser B, Rigotti P, Gridelli B, et al. Xenotransplantation of solid organs in the pig-to-primate model. Transpl Immunol. 2009;21:87-92.
9. Klymiuk N, Aigner B, Brem G, et al. Genetic modification of pigs as organ donors for xenotransplantation. Mol Reprod Dev. 2010;77:209-221.
10. Locke JE, Sun Z, Warren DS, et al. Generation of humanized animal livers using embryoid body-derived stem cell transplant. Ann Surg. 2008;248;487-493.
11. Mercer DF, Schiller DE, Elliott JF, et al. Hepatitis C virus replication in mice with chimeric human livers. Nat Med. 2001;7:927-933.
12. Tateno C, Yoshizane Y, Saito N, et al. Near completely humanized liver inmice shows human-type metabolic responses to drugs. Am J Pathol. 2004;165:901-912.
13. Hakamata Y, Murakami T, Kobayashi E. "Firefly rats" as an organ/cellular source for long-term in vivo bioluminescent imaging. Transplantation. 2006;81:1179-1184.
14. Horie M, Sekiya I, Muneta T, et al. Intra-articular injected synovial stem cells differentiate into meniscal cells directly and promote meniscal regeneration without mobilization to distant organs in rat massive meniscal defect. Stem Cells. 2009;27:878-887.
15. Oren R, Dabeva MD, Petkov PM, et al. Restoration of serum albumin levels in Nagase analbuminemic rats by hepatocyte transplantation. Hepatology. 1999;29:75-81.
16. Enosawa S, Suzuki S, Li XK, et al. Higher efficiency of retrovirus transduction in the late stage of primary culture of hepatocytes from nontreated than from partially hepatectomized rat. Cell Transplant. 1998;7:413-416.
17. Rong Xiu D, Hishikawa S, Sato M, et al. Rat auxiliary liver transplantation without portal vein reconstruction: comparison with the portal vein-arterialized model. Microsurgery. 2001;21:189-195.
18. Murase N, Starzl TE, Demetris AJ, et al. Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation. 1993;55:701-708.
19. Durand F, Renz JF, Alkofer B, et al. Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl. 2008;14:1694-1707.
20. Renz JF, Kin C, Kinkhabwala M, et al. Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation. Ann Surg. 2005;242:556-565.
21. Trotter JF, Adam R, Lo CM, et al. Documented deaths of hepatic lobe donors for living donor liver transplantation. Liver Transpl. 2006;12:1485-1488.
22. Steering Committee of the Istanbul Summit. Organ trafficking and transplant tourism and commercialism: the Declaration of Istanbul. Lancet. 2008;372: 5-6.
23. Dhawan A, Puppi J, Hughes RD, et al. Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol. 2010;7:288-298.
24. Selck FW, Grossman EB, Ratner LE, et al. Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool. Ann Surg. 2008;248: 599-607.
25. Demetriou AA, Brown RS, Busuttil RW, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg. 2004;239:660-670.
26. Starzl TE, Fung J, Tzakis A, et al. Baboon-to-human liver transplantation. Lancet. 1993;341:65-71.
27. Ekser B, Gridelli B, Tector AJ, et al. Pig liver xenotransplantation as a bridge to allotransplantation: which patients might benefit? Transplantation. 2009;88:1041-1049.
28. Giannini C, Morosan S, Tralhao JG, et al. A highly efficient, stable, and rapid approach for ex vivo human liver gene therapy via a FLAP lentiviral vector. Hepatology. 2003;38:114-122.
29. Ghebremariam YT, Smith SA, Anderson JB, et al. Intervention strategies and agents mediating the prevention of xenorejection. Ann N Y Acad Sci. 2005;1056:123-143.
30. Goto S, Lord R,Kobayashi E, et al. Novel immunosuppressive proteins purified from the serum of liver-retransplanted rats. Transplantation. 1996;61:1147-1151.
31. Tahara K, Murakami T, Fujishiro J, et al. Regeneration of the rat neonatal intestine in transplantation. Ann Surg. 2005;242:124-132
32. Bekker J, Ploem S, de Jong KP. Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors. Am J Transplant. 2009;9:746-757.
33. Tomiya T, Omata M, Imamura H, et al. Impaired liver regeneration in acute liver failure: the significance of cross-communication of growth associated factors in liver regeneration. Hepatol Res. 2008;38:S29-S33.
34. Mueller NJ, Takeuchi Y, Mattiuzzo G, at al.Microbial safety in xenotransplantation. Curr Opin Organ Transplant. 2011;16:201-206.
35. Onions D, Cooper DK, Alexander TJ, et al. An approach to the control of disease transmission in pig-to-human xenotransplantation. Xenotransplantation. 2000;7:143-155.
36. Michaels MG, Kaufman C, Volberding PA, et al. Baboon bone-marrow xenotransplant in a patient with advanced HIV disease: case report and 8-year follow-up. Transplantation. 2004;78:1582-1589.